May 5, 2020 / 11:13 AM / 21 days ago

BRIEF-Incyte Reports Q1 Loss Per Share Of $3.33

May 5 (Reuters) - Incyte Corp:

* INCYTE REPORTS 2020 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES UPDATES ON KEY CLINICAL PROGRAMS

* INCYTE CORP - TOTAL PRODUCT AND ROYALTY REVENUES OF $569 MILLION FOR QUARTER

* INCYTE CORP - RUXOLITINIB AND BARICITINIB IN CLINICAL TRIALS TO TREAT PATIENTS SUFFERING FROM COVID-19

* INCYTE CORP - QTRLY LOSS PER SHARE $3.33

* INCYTE CORP - QTRLY ADJUSTED LOSS PER SHARE $2.86

* INCYTE CORP - SEES 2020 JAKAFI NET PRODUCT REVENUES $1.88 BILLION - $1.95 BILLION

* INCYTE CORP - SEES 2020 ICLUSIG NET PRODUCT REVENUES $100 MILLION - $105 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below